XanTec bioanalytics offers the following products and services:
- Slides for Protein and DNA microarray production
- SPR sensorchips and instruments
- Custom coating with biocompatible nanocoatings
- Assay development
Xanthus Pharmaceuticals, Inc. develops therapeutic compounds with strong historical success indicators through the experience and insight of its veteran management team.
Xantos evaluates and provides therapeutic targets and leads for LMW drugs and target for genes, proteins and antibodies for direct therapeutic use as well as diagnostic targets.
Xceed Capital Ltd (Xceed) is an investment company based in Perth, Australia and is listed on the Australian Stock Exchange (ASX: XCD). Historically, Xceed has worked closely with CSIRO to successfully spin-off two companies.
Xceleron is expert-acknowledged to deliver a range of smart approaches to Exploratory Clinical Studies in Microdosing, Mass Balance, Absolute Bioavailability and Metabolite Profiling.
XDx has applied microarray, real-time PCR (polymerase chain reaction) and bioinformatics technologies to develop a new way to monitor the immune system. The company's first commercial service, AlloMap molecular expression testing is a noninvasive, multi-g
Xemplar provides the most sophisticated aerosol formulation and development technologies and product development support services to meet precise needs.
Xentec Limited provide bespoke applications and consultancy services to a wide variety of customers from Health Services to Service and Construction Industries
XenoBiotic Laboratories, Inc. is a leading contract laboratory specializing in preclinical ADME, PK/TK, in vitro/vivo drug metabolism, human radiolabel studies, bioanalytical method development/validation and clinical sample analysis.accredited
Xenogen Biosciences, a contract research organization, specializes in
genetic modification of mice and rats using gene addition, gene targeting,homologous recombination and microinjection techniques.
Xenogenics Corporation, subsidiary of MultiCell Technologies, Inc., holds rights and patents to the development-stage SybiolR synthetic bio-liver. It is an excorporeal cellular therapy device, comparable to dialysis, designed to treat liver patients.
Xenometrix is a company specialized in the production, distribution and service of mutagenicity test systems, namely Ames II, Ames MPF 98/100, Ames MPF 1535, Ames MPF 1537, Ames MPF E.coli WP2 uvrA, Ames MPF E.coli WP2 pkM101
Xeno Medical has over 45 years experience in the field and has operated at the highest levels of international industry and academia. We have demonstrable results in business creation, adding value, technology transfer, market entry and due diligence.
We empower individuals, organizations and businesses with our unique services. Diversification being our core strategy; we specialize in Xenon, Murray Feiss, Table Lamp and an array of other services.
Xenon is a privately owned, genomics-based drug discovery and development company engaged in identifying genes and other drug targets associated with human disease and developing pharmaceutical therapies based on these genetically-derived targets.
XenoPort Inc. is a privately held biopharmaceutical company focused on developing products which harness the body's intrinsic transport systems to improve the oral absorption, distribution, and pharmacokinetics of drugs.
Founded in 1996, Xenos Bioresources, Inc. (XBI) was organized with the objective of providing the biotechnology, biopharmaceutical, veterinary and nutraceutical industries with the best available products to meet their sourcing needs
Our primary focus is filtration, sample preparation and liquid chromatography for a wide range of environmental and pharmaceutical applications. In addition to a full line of optimized products, we work with clients to develop proprietary solutions for th
A consultation on xenotransplantation. Xenotransplantation is the use of live, non-human animal cells, tissues and organs in humans. Xenotransplants could potentially provide an alternative source of organs and tissues for patients in Canada.
Xeotron produces customizable, high density, long oligo microarrays. Researchers can now have complete control of the content of high quality gene expression studies without the high upfront costs and delays - any gene, any species, no minimum order.
XEPTAGEN SpA is engaged in the discovery and validation of novel molecular markers in order to produce innovative diagnostic kits for the early detection, monitoring, and screening of cancerous cells
Xerion focuses on proteins and has assembled and combined unique and effective technologies for drug target identification (Xcelerate), validation (XCALIbur) and functional site identification (X-plore).
Website Update in progress Nov 06.
Xgene Corporation is a biological research company that provides innovative solutions to problems facing pharmaceutical, consumer product, chemical, and cosmetic companies
XIA LLC (formerly X-ray Instrumentation Associates) produces advanced X-ray and gamma-ray detector electronics and related instruments with applications in research and industry.
Xiamen Doingcom Chemical Company Limited (“Doingcom”)is the subsidiary of EcoGreen Fine Chemicals Group Limited (listed on the main board of the Hong Kong Stock Exchange Market).
Xi`an Libang Group Investment Co.,Ltd mainly engagesin research, development, production and sales of generic and proprietary branded pharmaceuticals and activepharmaceutical ingredients.
Xiangquan Chromtech Development Centre is a leading filter products and lab equipment company in China, organized into two divisions. The Filter products division specializes in syringe filters and membrane filters using for sample preparation. The